GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (NSE:BLISSGVS) » Definitions » Debt-to-Asset

Bliss GVS Pharma (NSE:BLISSGVS) Debt-to-Asset : 0.00 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Bliss GVS Pharma Debt-to-Asset?

Bliss GVS Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Bliss GVS Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Bliss GVS Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₹0 Mil.


Bliss GVS Pharma Debt-to-Asset Historical Data

The historical data trend for Bliss GVS Pharma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma Debt-to-Asset Chart

Bliss GVS Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.11 0.10 0.09 0.08

Bliss GVS Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.08 - 0.07 -

Competitive Comparison of Bliss GVS Pharma's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Bliss GVS Pharma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bliss GVS Pharma's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bliss GVS Pharma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bliss GVS Pharma's Debt-to-Asset falls into.



Bliss GVS Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bliss GVS Pharma's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(549.692 + 448.709) / 12138.684
=0.08

Bliss GVS Pharma's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bliss GVS Pharma  (NSE:BLISSGVS) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Bliss GVS Pharma Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bliss GVS Pharma Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from exports.

Bliss GVS Pharma Headlines

No Headlines